Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 691 AL 705

Comparing clinical effect sizes of Souvenaid(TM), lecanemab, and donanemab in early Alzheimer's disease

Solfrizzi V, Imbimbo BP.

J Alzheimers Dis. 2026 Feb;109(3):1258-1263. doi: 10.1177/13872877251406221. Epub 2025 Dec 22.

Gamma sensory stimulation: Investigating human brain response to optimize clinical translation

Manippa V.

J Alzheimers Dis. 2026 Feb;109(4):1628-1629. doi: 10.1177/13872877251407709. Epub 2025 Dec 19.

Tolerability of rivastigmine transdermal patch in patients with Alzheimer's disease: a narrative review

García Ribas G, Ferrer-Picón E.

Expert Opin Drug Saf. 2026 Apr;25(4):643-655. doi: 10.1080/14740338.2025.2576520. Epub 2025 Oct 31.

Enhanced quality in primary care for elders with diabetes and dementia: Protocol for a multisite randomized controlled trial

Adeyemi O, Christina W, Arcila-Mesa M, Dickson VV, Ferris R, Tarpey T, Fletcher J, Blaum C, Chodosh J.

Contemp Clin Trials. 2026 Jan;160:108165. doi: 10.1016/j.cct.2025.108165. Epub 2025 Nov 24.

Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's Disease

Pérez-Ruixo C, Li L, Galpern WR, Perez-Ruixo JJ.

Clin Pharmacol Ther. 2026 Apr;119(4):979-989. doi: 10.1002/cpt.70173. Epub 2025 Dec 22.

Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis

Shim GH, Lau ECY, Huynh ALH, Lu CY, Tan ECK.

Ageing Res Rev. 2026 Jan;114:102981. doi: 10.1016/j.arr.2025.102981. Epub 2025 Dec 4.

Effects of triptolide herb on the progression of Alzheimer's disease preclinical models: a systematic review

Shami R, El Majzoub R, Ismail A, Kotaich J, Kassem M, Safadieh G, Fayyad-Kazan M, Chahine B.

Neurodegener Dis Manag. 2026 Apr;16(2):239-251. doi: 10.1080/17582024.2025.2562776. Epub 2025 Sep 24.

[Systematic review and mechanistic exploration of "intelligence three-needling" in treatment of Alzheimer's disease]

Zhou R, Li J, Liu W, Zheng R, Han J, Liao Z, Ning W, Tang C.

Zhongguo Zhen Jiu. 2026 Jan 12;46(1):153-160. doi: 10.13703/j.0255-2930.20250723-k0001. Epub 2025 Oct 22.

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases

Villarejo Galende A, González-Sánchez M, Hilario A, Llamas-Velasco S, Morenas-Rodríguez E, Muñoz-García MI, Ramos-González A, Pérez-Martínez DA, Blanco-Palmero VA.

J Alzheimers Dis. 2026 Feb;109(3):1099-1116. doi: 10.1177/13872877251404505. Epub 2025 Dec 12.

Anthocyanins in the treatment of Alzheimer's disease: a systematic review and meta-analysis of animal studies

Chen YN, Xiong ZE, Wen X, He SJ, Zhang XL, Zhang R, Wang T, Zou J.

Nutr Neurosci. 2026 May;29(5):595-612. doi: 10.1080/1028415X.2025.2578641. Epub 2025 Oct 30.

Efficacy and safety of a novel, extended-release rivastigmine transdermal patch (TW-4752N) in patients with Alzheimer's disease: A 24-week randomized, double-blind trial with a 28-week open-label extension

Nakamura Y, Kurokawa T, Terashima S, Nishimura A.

J Alzheimers Dis. 2026 Jan;109(2):1007-1019. doi: 10.1177/13872877251401601. Epub 2025 Dec 9.

Efficacy and Safety of Gantenerumab in Patients With Alzheimer Disease: A Systematic Review and Meta-analysis

Alla D, Malireddi A, Ramsundar R, Shah D, Alla SSM, Das A, Andanappa A, Emmanuel NW, Siddiqui S, Marepalli NR, Dugyala RR, Kolte R.

Clin Neuropharmacol. 2026 Jan-Feb 01;49(1):4-10. doi: 10.1097/WNF.0000000000000661. Epub 2025 Nov 24.

Equine-Assisted Intervention and Alzheimer's Disease: A Non-randomized, Controlled, Multicenter Study

Badin L, Bailly N.

J Appl Gerontol. 2026 Apr;45(4):655-664. doi: 10.1177/07334648251351697. Epub 2025 Jun 18.

Safety and efficacy of transcranial ultrasound stimulation for the treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial

Fuh JL, Wang SJ, Wang PN, Wu HM, Su WS, Lin HM, Yang FY.

Ultrasonics. 2026 Mar;159:107844. doi: 10.1016/j.ultras.2025.107844. Epub 2025 Oct 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias